Fen Phen Class Action Settlement Judge Approves Payment of Seven Hundred Ninety Million Dollars

Wyeth Lawsuit Supreme Court Ruling March 2009
Wyeth Lawsuit Supreme Ruling March 2009
Fen Phen drug recall class action judge Harvey Bartle issued a federal court order today in Philadelphia approving a final distribution of the fen phen supplemental class settlement fund. Judge Bartle’s order authorized payment of $792,694,924 to consumers who suffered heart valve injury from the once popular diet drug combination known as fen phen. The drugs Pondimin and Redux were removed from the market in 1997 by Wyeth, a pharmaceutical manufacturer after it was shown that the drug could cause heart valve lesions and a usually fatal disease called Primary Pulmonary Hypertension or PPH. The diet drug class settlement agreement was reached in 1999 and billions of dollars have been paid since that time to fen phen users who sustained heart valve damage. Lawsuits are still being filed against Wyeth for primary pulmonary hypertension (PPH) now more properly know as arterial pulmonary hypertension. The fen phen class settlement process was fraught with delays and controversy. Beneficiaries of this multimillion dollar distribution have been waiting for over ten years to receive this compensation.
Fen Phen Class Action Lawyer
Fen Phen Class Action Lawsuit Website
Fen Phen Attorney Homepage